Nuffield Orthopaedic Centre, WindmillRoad, Headington, OxfordOX3 7LD, UK.
Bone Joint Res. 2013 Jun 1;2(6):96-101. doi: 10.1302/2046-3758.26.2000154. Print 2013.
Guidelines for the management of patients with metastatic bone disease (MBD) have been available to the orthopaedic community for more than a decade, with little improvement in service provision to this increasingly large patient group. Improvements in adjuvant and neo-adjuvant treatments have increased both the number and overall survival of patients living with MBD. As a consequence the incidence of complications of MBD presenting to surgeons has increased and is set to increase further. The British Orthopaedic Oncology Society (BOOS) are to publish more revised detailed guidelines on what represents 'best practice' in managing patients with MBD. This article is designed to coincide with and publicise new BOOS guidelines and once again champion the cause of patients with MBD.
A series of short cases highlight common errors frequently being made in managing patients with MBD despite the availability of guidelines.
Despite guidelines for the management of patients with MBD being available for more than a decade basic errors in management continue to be made, affecting patient survival and quality of life.
It is hoped that by publicising the new BOOS guidelines the management of patients with MBD will improve over the next decade, significantly more than it has over the last decade.
治疗转移性骨病（MBD）患者的指南已经在矫形外科领域存在了十多年，但是为这个日益庞大的患者群体提供的服务并没有明显改善。辅助和新辅助治疗的改进增加了患有 MBD 的患者的数量和整体存活率。因此，MBD 并发症的发生率在增加，并将进一步增加。英国矫形骨肿瘤学会（BOOS）将就如何管理 MBD 患者的“最佳实践”发布更多修订后的详细指南。本文旨在配合并宣传新的 BOOS 指南，并再次为 MBD 患者争取权益。
一系列简短的病例突出了尽管有指南，但在管理 MBD 患者时经常犯的常见错误。
尽管 MBD 患者的管理指南已经存在了十多年，但管理中的基本错误仍在继续，影响患者的生存和生活质量。
希望通过宣传新的 BOOS 指南，在未来十年内 MBD 患者的管理将得到改善，改善程度将大大超过过去十年。
